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Background: The prevalence of overweight, obesity and diabetes mellitus has increased in 
Mexico, therefore, sucralose and stevia are being used as alternative non-caloric sweeteners to 
reduce energy intake. Moreover, poorly balanced diets can lead to the formation of carbonyl 
groups, a marker used to determine oxidative damage to proteins. Increased presence of 
carbonylated proteins in CD1 mice chronically consuming sweeteners, may point them as causing 
oxidative damage. 
Aims: To determine whether the continued use of natural and artificial sweeteners increases the 
presence of carbonylated proteins in lymphocytes of lymphoid tissues in CD1 male mice. 
Methods: The present study was conducted with 72 CD1 newly weaned (21-day old) male mice, 
fed with standard lab diet and water ad libitum; mice were hosted in cages in groups of 4 under 
controlled temperature conditions (19-21°C), and light/dark cycles of 12/12 h. Weight and food 
intake was quantified weekly. Three groups of mice were randomly conformed: a) Baseline (21-day 











old, newly weaned, n=8); b) 6-week of treatment (63-day old, n=32); c) 12-week of treatment (105-
day old, n=32). Groups b and c were divided into 4 subgroups each (n=8): i) Control (CL) without 
sweeteners; ii) Sucrose (SUC); iii) Sucralose (SUCL), and iv) Stevia (ST). Body weight, food, and 
water consumption were measured, and BMI was calculated from those values. Lymphocytes from 
Peyer's patches, peripheral blood and spleen were isolated, and from these cells carbonylated 
protein concentration was quantified. Blood glucose was also assessed. 
Results: Mice in SUCL and ST groups had lower weight gain and BMI compared to those that 
consumed SUC. The SUCL group consumed more food and the ST group decreased food intake, 
as compared with SUC and control groups. ST group drank more sweetened water, compared to 
the other groups. The percentage of blood lymphocytes and the carbonylated proteins 
concentrations were higher in the SUCL group. 
Conclusions: The chronic consumption of sucralose, caused an increase in food intake. In 
addition, the percentage of lymphocytes circulating in blood was elevated, as well as the 
concentration of carbonylated proteins in these cells. 
 
 




BMI :  Body Mass Index 
CL :  Control 
GALT :  Gut-associated Lymphoid Tissue 
ROS :  Reactive Oxygen Species 
ST :  Stevia 
SUC :  Sucrose 
SUCL :  Sucralose 
 
1. INTRODUCTION  
 
The prevalence of chronic diseases such as 
overweight, obesity and diabetes mellitus has 
increased over the last years [1]. Because of this, 
an alternative to reduce the energy intake from 
food is to replace sweetened foods and 
beverages by those with non-caloric substitutes, 
both natural and artificial [2]. The most widely 
used artificial sweetener is sucralose, followed by 
stevia of natural origin [3]. Sucralose is 600 times 
sweeter than sucrose; it is synthesized by 
selective halogenation of sucrose and it is not 
metabolized or stored, instead of, it is excreted 
unchanged in urine and feces [4, 5]. In addition, it 
is pH and temperature resistant, which makes 
sucralose perfect for confectionery [6]. On the 
other hand, stevia is extracted from leaves of the 
plant Stevia rebaudiana [7]; its sweetening power 
is 300 times greater than SUC [8]. ST is 
transported by facilitated diffusion in the intestinal 
epithelium, and by a monocarboxylic transporter 
towards the blood; in urine, it is excreted as 
steviol glucuronide and in feces as free steviol 
[9]. The use of sweeteners is approved by the 
Food and Drug Administration in the United 
States, and in Mexico by The Ministry of Health, 
and published in the Official Mexican Standard 
NOM-218-SSA1-2011 [10], in products such as 
non-alcoholic beverages (soft drinks), candies, 
frozen and baked desserts, canned fruits and 
fruit juices [2,11], but their long-term effects are 
still controversial and the studies are 
inconclusive.   
 
1.1 Lymphoid Organs  
 
Lymphoid tissue is widely distributed in the 
organism and is responsible for monitoring and 
protecting the organism against unknown 
substances. Lymphoid tissue consists of primary 
organs precursors of lymphocytes (thymus and 
bone marrow) and secondary organs such as 
lymph nodes, spleen, tonsils and Mucosal-
Associated Lymphoid Tissue [12], which is 
divided into Bronchial-Associated Lymphoid 
Tissue [13], and Intestinal-Associated Lymphoid 
Tissue (GALT). These organs and tissues harbor 
mature immune cells, which interact with 
antigens and trigger immune response [14]. In 
addition, there are sites of induction of the 
immune response in GALT such as Peyer’s 
patches, solitary lymphatic nodules and the 
lamina propria as an effector site [15]. Peyer’s 
patches are located along the small intestine and 
mainly contain B-lymphocytes which synthesize 
immunoglobulin A [14], and they are the first 
contact site in the gastrointestinal tract with 
antigens [16]. 
 
1.2 Protein Oxidative Damage  
 
Reactive oxygen species (ROS) are free radicals 
resulting from normal cellular metabolism and 
they play both, harmful and beneficial roles in 
cellular systems [17]. When overproduced, free 
radicals cause biological damage to main 











oxidative stress [18], which induces 
mitochondrial dysfunction, cytotoxicity and 
apoptosis. Localization and effect caused by 
oxidative stress can be measured through 
biomarkers assessed from tissue and fluids [19].  
 
Proteins are very susceptible to free radical 
attacks, the most used biomarker to assess 
protein damage is the protein carbonyl assay 
[20]. The damage caused by ROS to proteins is 
an irreversible process, which can increase 
erroneous folding of secondary and tertiary 
protein structures. Among the main modifications 
that proteins undergo after oxidation are loss of 
catalytic activity, amino acid modifications, 
carbonyl group formation, thermal stability 
alteration, fragmentation, formation of erroneous 
disulfide bridges and higher susceptibility to 
proteolysis [21]. The most frequently oxidized 
amino acids are phenylalanine, tyrosine, 
tryptophan, histidine and methionine, and such 
oxidation forms carbonylated proteins, which 
favor cross-linking between proteins or with other 
biomolecules such as glucose (glycosylation). 
Formation of carbonyl compounds is used as the 
main marker to determine severe protein 
oxidation, both in vitro and in vivo. As biomarkers 
of oxidative damage to proteins, carbonyls have 
been shown to accumulate with age, causing 
ischemic disease and chronic inflammation [19]. 
Therefore, the cells are a suitable site for the 
accumulation of carbonylated proteins depending 
on the magnitude of exposure to ROS. The 
objective of this study was to determine if the 
chronic use of natural and artificial sweeteners 
increases the presence of carbonylated proteins 
in lymphocytes of lymphoid organs in male CD1 
mice. 
 
2. MATERIALS AND METHODS  
 
2.1 Animals  
 
The present study was conducted with 72 CD1 
newly weaned (21-day old) male mice, fed with 
standard lab diet (Rodent Laboratory Chow 5001 
Purina [3.02Kcal/gr]) and water ad libitum. Initial 
weight was 19.5-22.3 g; mice were hosted in 
cages in groups of 4 under controlled 
temperature conditions (19-21°C), and light/dark 
cycles of 12/12 h. The production, care and 
handling of laboratory animals were according to 
the Official Mexican Standard NOM-062-ZOO-
1999 [22]. The project was approved by the 
Bioethics Committee of the Faculty of Medicine, 
of the Autonomous University of the State of 
Mexico. Weight and food intake were quantified 
weekly. Three groups of mice were randomly 
formed: a) Baseline (21-day old, newly weaned, 
n=8); b) 6-week of treatment (63-day old, n=32); 
c) 12-week of treatment (105-day old, n=32). 
Groups b and c were divided into 4 subgroups 
each (n=8): i) Control without sweeteners (CL); ii) 
Sucrose (SUC); iii) Sucralose (SUCL) and iv) 
Stevia (ST).  
 
2.2 Sweetener Preparation  
 
Sweeteners were obtained from commercial 
formulas, administered as solutions in the water 
supply ad libitum as: 41.66 mg/mL SUC 
(Sucrose), 4.16 mg/mL SUCL (Splenda®) and 
ST (Svetia®) in accordance with the 
recommendations of the Official Mexican 
Standard NOM-218-SSA1-2011, for non-
alcoholic flavored beverages [10]. Sweetener 
consumption was quantified weekly, considering 
>3 weeks intake as chronic consumption. 
 
2.3 Morphometric and Nutritional 
Determinations  
 
Mice weight and body length (nose-anus) were 
measured at baseline, 6 and 12-week of 
treatment. Weight and length were used to 
determine Body Mass Index (BMI) = weight (g)/ 
[length (cm)]2. Daily energy intake per mice 
(kJ/day) was calculated from the proportion of 
weekly food and sweetener intake per cage. 
 
2.4 Collection and Processing of Samples  
 
Groups of mice were sacrificed at baseline, 6 
and 12-week of treatment, by cervical dislocation 
[22], blood was obtained through direct cardiac 
puncture and lymphocytes were isolated using 
Ficoll-Hypaque Plus (GE Healthcare BioSciences 
AB, Sweden). Spleen and Peyer´s patches were 
removed and placed in Petri dishes with PBS 
buffer (3 mL), manually homogenized and filtered 
using nylon mesh (40 µm) to remove remaining 
connective tissue. Afterwards, samples were 
centrifuged at 2500 rpm/5min; cell pellets 
obtained from spleen were put in a hypotonic 
buffer solution (8.26 g/L of NH4Cl, 1 g/L of 
KHCO3 and 0.037 g/L of EDTA-Na, pH 7.4) to 
lyse red blood cells. The cell suspensions 
isolated from blood, spleen and Peyer's patches 
were washed with PBS. Cell viability of the 
isolated lymphocytes was immediately assessed 
with a trypan blue assay. The lymphocytes were 
counted in a Neubauer chamber to obtain the 











2.5 Determination of Carbonylated 
Proteins  
 
The lymphocytes (1x106/mL PBS solution) were 
lysated using a tissue homogenizer (DragonLab 
model D-160) at 8000 rpm, then centrifuged for 5 
min at 2500 rpm, the supernatant was used for 
the quantification of carbonylated proteins. The 
groups of carbonylated proteins were detected 
and quantified using the 2,4-
dinitrophenylhydrazine (DNPH) assay. Briefly, 
0.5 mL of the supernatant was treated with 0.5 
mL 10 mM DNPH in 2 M hydrochloric acid, or 
with 0.5 mL 2 M hydrochloric acid alone as a 
blank. The samples were incubated for 1 h at 
room temperature in the dark, treated with 10% 
trychloroacetic acid, and centrifuged. The pellet 
was washed three times with ethyl 
acetate/ethanol (1:1 v/v) and rinsed with 1 mL of 
6 M guanidine hydrochloride in 20 mM potassium 
phosphate, pH adjusted to 2.3 with hydrochloric 
acid; the resulting solution was incubated at 37 
°C for 15 min. Reading of the assay was 
performed on a spectrophotometer, at ƛ 370nm 
using 1mL of 6M guanidine hydrochloride for 
calibration. The carbonyl concentration was 
determined by the absorbance difference 
between the sample treated with 
dinitrophenylhydrazine and hydrochloric acid. 
The carbonyl content was expressed in 
nanomoles of carbonyls per milligram of protein. 
 
2.6 Blood Glucose Quantification  
 
Blood glucose was measured with a Bayer 
Contour TS glucometer at baseline, 6 and 12-
week of treatment.  
 
2.7 Statistical Analysis  
 
Results are expressed as mean ± SD (n = 8). 
Data were analyzed with one-way and two-way 
ANOVA. Differences were considered significant 
at p <0.05, the statistical package SPSS version 
19.0 was used for all statistical analyzes (SPSS 
Inc., Chicago, IL, USA).  
 




3.1.1 Body weight and body mass index of 
mice  
 
At baseline, all groups showed no significant 
differences in BMI. The administration of ST after 
12-week of treatment did not produce a 
significant increase in the animals' weight (one-
way ANOVA F= 6.18, p<0.002); the Bonferroni 
post hoc test showed difference in weight 
between the groups that consumed SUC and ST 
(Table 1). BMI determined at 6-week of treatment 
showed no significant differences between 
subgroups. In the 12-week treatment group, BMI 
increased (one-way ANOVA F=3.27, p<0.023) in 
the SUC subgroup (Bonferroni test, p<0.020).  
 
3.1.2 Energy and food intake 
 
Energy intake in the 6 and 12-week groups 
showed significant differences (two-way ANOVA 
F=10.83, p<0.33). In the 6-week treatment group 
differences were observed (one-way ANOVA 
F=125, p<0.001), SUC and SUCL subgroups 
showed an increase when compared with the CL 
subgroup (Bonferroni test, p<0.001), while ST 
showed no differences (Bonferroni test, 
p>0.050). In a similar way, the 12-week 
treatment group showed significant differences 
between subgroups (one-way ANOVA F=21, p 
<0.001), being the SUCL group the one showing 
the highest increase as compared to the other 
subgroups (Bonferroni test, p<0.001)  (Table 1). 
Food intake in the 6 and 12-week treatment 
groups showed significant differences (one-way 
ANOVA F=11.94, p<0.043); in 6-week treatment 
group, SUC and SUCL showed a higher food 
intake when compared with CL group (Bonferroni 
test, p<0.001). However, in the 12-week 
treatment group the increase was only observed 
in SUCL group (Bonferroni test, p<0.001). 
 
3.1.3 Blood glucose determinations  
 
At 6-week of treatment, blood glucose 
concentrations increased (one-way ANOVA 
F=2.59, p<0.007) in SUC, SUCL and ST 
subgroups, as compared with CL (Bonferroni 
test, p<0.001). In the 12-week treatment group, 
glucose concentrations increased (one-way 
ANOVA F=5.28, p<0.005) in SUC and SUCL 
subgroups (Bonferroni test, p<0.001), but 
decreased in the ST subgroup (Bonferroni test, 
p<0.018). After the 12-week treatment, we 
observed that chronic sweetener consumption 
had a significant effect (two-way ANOVA F=20, 
p<0.001) on blood glucose concentration, 
particularly with chronic consumption of SUCL 
(Bonferroni test, p<0.047), however, this effect 
was not observed at 6-week of treatment 













3.1.4  Percentage of lymphocytes in Peyer’s 
patches, peripheral blood and spleen  
 
Lymphocyte percentage obtained from Peyer’s 
patches of the small intestine of CD1 mice at 6-
week of treatment showed an increase in the 
SUC subgroup, while the SUCL and ST 
subgroups decreased, when compared to the CL 
subgroup. In the 12-week group, concentrations 
of lymphocytes in Peyer’s patches decreased in 
the SUC subgroup (one-way ANOVA F=3.5, 
p<0.028), compared to the CL group (Bonferroni 
test, p<0.022), therefore, showing differences 
from baseline to 12-week of treatment 
(Bonferroni test, p<0.001). When analyzing 
subgroups, percentage of lymphocytes in Peyer’s 
Patches was significantly decreased with ST 
treatment compared to control group (Bonferroni 
test, p<0.028). In the 6-week treatment group we 
found significant differences (one-way ANOVA 
F=13, p<0.001), being SUC and SUCL 
subgroups lower (Bonferroni test, p<0.001 for 
both groups). Furthermore, at 12-week of 
treatment this percentage increased significantly 
(one-way ANOVA F=31, p<0.001) with SUCL 
compared to SUC, ST and CL (Bonferroni test, 
p<0.001 respectively); conversely, ST group had 
significantly lower values when compared to CL 
group (Bonferroni test, p<0.001) as shown in 
Table 2. 
 
The duration of sweetener intake (mL/day) had a 
significant outcome in spleen lymphocyte 
percentage (two-way ANOVA F=35, p<0.001), 
especially between baseline and 12-week of 
treatment (Bonferroni test, p<0.001). Percentage 
of splen lymphocytes were modified in the 6-
week treatment group (one-way ANOVA F=11, 
p<0.001), decreased in SUC (Bonferroni test, 
p<0.049) and increased in SUCL (Bonferroni 
test, p<0.035), both compared with CL group. 
Moreover, in the 12-week treatment group, this 
modification persisted (one-way ANOVA F=7.5, 
p<0.001); in the SUCL group cell percentage 
remained increased (Bonferroni test, p<0.003) as 
shown in Table 2. 
 
Oxidative Stress determination by Carbonylated 
protein quantification in lymphocytes from 
Peyer’s patches, peripheral blood and spleen. 
 
The concentration of carbonylated proteins in 
lymphocytes obtained from Peyer’s patches did 
not show differences in any study group (6-week 
treatment group: One-way ANOVA F=0.26, 
p<0.850 and 12-week’ treatment group: One-way 
ANOVA F=2.4, p<0.082). The duration of 
treatment caused significant differences (Two- 
way ANOVA F=8.01, p<0.001) with the 12-week 
administration (Bonferroni test, p<0.018) (Table 
3). The carbonylated protein concentration in
Table 1. Mean morphometric values of food, energy and water consumption in subgroups of 
CD1 mice with sweetener supply 
 
 CL SUC SUCL ST  p  
Mean±SD Mean±SD Mean±SD Mean±SD 
6-week treatment       
Weight (g/week) 33.47±3.22 32.30±2.02 34.37±1.35 34±1.79 0.282 


















































































Table 2. Lymphocytes in Peyer’s patches, blood and spleen that consumed sweeteners 
 

















Baseline   
Peyer’s patches 25.37±1.63  1.0 
Peripheral blood 21±3.85 1.0 
Spleen  69.75±4.35 1.0 




















12-week’ treatment      










Spleen 194.87±9.71a 87.5±6.29 b 276.5±58.47c 114.87±21.93d 0.001* 
 
Table 3. Concentration of carbonylated proteins in lymphocytes from Peyer’s patches, blood 
and spleen in CD1 mice that consumed sweeteners 
 













Baseline       
Peyer’s patches 1.17±0.14 1.00 
Peripheral blood 0.266±0.08 1.00 
Spleen  1.32±0.18 1.00 
6-week treatment      
Peyer’s patches 0.480±0.15 0.642±0.174 0.500±0.159 0.602±0.115 0.85 
Peripheral blood 0.794±0.303 0.341±0.062 1.03±0.297 0.432±0.144 0.13 
Spleen  1.08±0.55 0.683±0.27 0.495±0.17 1.21±0.39 0.51 
12-week treatment      
Peyer’s patches 0.700±0.256 0.426±0.123 0.094±0.036 0.606±0.169 0.082 
Peripheral blood 0.448±0.203a 0.664±0.192b 1.38±0.291c 0.476±0.153a 0.016* 
Spleen 1.06±0.34 0.597±0.19 0.355±0.13 0.751±0.21 0.27 
 
blood lymphocytes was not modified at 6-week of 
treatment (One-way ANOVA F=2.02, p<0.13), 
while there was an increase at 12-week (One-
way ANOVA F=4.06, p<0.016), especially in the 
SUCL subgroup compared with the controls 
(Bonferroni test, p<0.03). When comparing time 
of administration (Two-way ANOVA F=9.5, 
p<0.001) and sweetener treatment (Two-way 
ANOVA F=4.1, p<0.003), we found differences in 
chronic intake of SUCL between 6 and 12-week 
in comparison with the CL group. Spleen 
lymphocytes did not show differences (One-way 
ANOVA F= 0.78, p<0.51 and F=1.3, p<0.27 




Diet plays a fundamental role in health; when 
unbalanced, it becomes an important risk factor. 
High sucrose diets are associated with excess 
energy consumption and poor food quality, which 
increase the risk of developing obesity, type 2 
diabetes and cardiovascular diseases. In this 
study, mice in SUCL and ST subgroups had 
lower weight gain and BMI compared to those 
consuming sucrose. This increase in weight is 
derived from the predilection for sweet foods, 
which are consumed in greater proportion; in 
addition, the consumption of sucrose increases 
the energy content of the diet, which generates 
an increase in body weight [23]. Furthermore, 
Figlewicz [24] reported that chronic consumption 
of stevia does not increase body weight or total 
weight gain in rats. In another study in rats 
consuming 10% sucrose for 10 weeks, a 
significant weight gain was observed [25]. This 
agrees with the present study, since the weight 











compared to the ST, SUCL and CL subgroups. 
Thus, weight gain can be attributed to the 
preferred type of sweetener [26], although some 
studies associate the consumption of sucralose 
with weight gain in animals that consumed it at 
low doses [27].  
 
At the end of the study the animals in the SUCL 
subgroup consumed more food; the ST subgroup 
decreased its consumption compared to the SUC 
and CL subgroups. The ST subgroup consumed 
more sweetened water as compared with the 
other subgroups. The predilection for consuming 
a specific sweetener is variable among rats, mice 
and humans. In the study by Bello [28], they 
found that male rats showed a characteristic 
pattern of indifference-evasion for SUCL 
consumption, acknowledging that they prefer 
simple water to a sweet solution. This preference 
is different between rodent species (rats vs. 
mice) and between strains of mice. This study 
was performed in male CD1 mice, which may 
explain the predilection for ST. However, in rats 
that consume high amounts of water with 
glucose when they have free access to it, it is not 
yet clear whether it is because of the sweet taste 
of the solution or because of the effect caused by 
the intake of large amounts of glucose [26]. 
 
Also, SUC and SUCL increased the glycaemia of 
the animals after 12-week of chronic sweetener 
consumption. This allows us to show that the 
consumption of sucralose is not completely 
harmless. These results agree with the study by 
Pepino MY [29], in a human experimental model, 
where SUCL was shown to increase plasma 
glycemic levels. In a rat model research, it was 
suggested that SUCL consumption has 
metabolic effects [30], since non-caloric 
sweeteners can alter glucose homeostasis by 
activating sweet taste receptors in the gut [31]. 
This may be explained by the fact that SUCL 
stimulates higher food intake, this may be the 
cause of the elevation of glucose in this study. 
There is still controversy over the effects of low-
energy sweetener consumption on body weight 
and blood glucose. According to Lee Grotz V 
[32], who studied the effect of high consumption 
of SUCL (7.5 mg/kg/day), three times the 
recommended maximum intake dose, for 3 
months in diabetic patients and concluded that it 
has no effect on glucose homeostasis in subjects 
with type 2 diabetes mellitus.  
 
There is currently controversy about systemic 
adverse effects from ST and SUCL consumption, 
including the effect on the immune system and 
protein carbonylation.  Researches carried out by 
Goldsmith [5], Grice and Goldsmith [32], and 
Grotz [33] indicate that chronic administration of 
SUCL produces no signs of toxicity or other 
adverse effects, Tordoff [34] suggest that the 
consumption of SUCL does not produce weight 
gain in rats and that they prefer sweet foods. As 
well, Dhingra R and cols. [35] and  Nettleton JA 
[36] who conducted research comparing the diet 
of people with and without Type 2 Diabetes 
Mellitus, finding that there is an association 
between the consumption of dietary drinks 
(sweetened with artificial sweeteners, among 
them SUCL) with increase of body weight, 
development of cardiovascular diseases and risk 
of suffering Metabolic Syndrome and Diabetes 
Mellitus type 2, but the controversy is that dietary 
beverage consumption is higher among 
individuals with type 2 Diabetes Mellitus 
compared to those without type 2 Diabetes 
Mellitus. In this study, we only used healthy mice; 
it is advisable to carry out tests in diabetic mice 
in the future. 
 
The chronic consumption of sweeteners 
decreased the percentage of lymphocytes in 
Peyer’s patches with the consumption of SUC, 
SUCL and ST. In blood and spleen, the 
percentage of lymphocytes decreased 
significantly with ST and SUC consumption, 
increasing in the SUCL group. In the present 
study, we observed that SUCL elevates the 
concentration of carbonylated proteins as a 
marker of oxidative stress in peripheral blood 
lymphocytes, besides increasing the number of 
circulating cells; therefore, it is necessary to 
evaluate the function of the cells. Additionally, ST 
reduced the concentration of carbonylated 
proteins in Peyer’s patches, blood and 
percentage of spleen lymphocytes, possibly 
derived from the antioxidant effect that has been 
described before [37]. In addition, a few studies 
exist that analyze the effect of consuming 
sweeteners for prolonged periods and in early 
ages of life; the same happened with the effect 
on the immune system at the intestinal mucosa.  
 
The connection between the use of sweeteners, 
the immune system and health are actually under 
intense investigation, more research is required 
to clarify their participation in the organism. 
 
In vitro studies have shown that natural 
sweeteners like ST improve IL-6 concentrations; 
while artificial ones, as SUCL suppress their 
secretion, and reduce biomarkers of humoral 











effects of non-nutritive sweeteners have been 
reported such as increased intestinal glucose 
absorption, alterations in intestinal microbiota, 
induction of oxidative stress and deregulation of 
appetite reward response [37]. In 2008, the study 
by Abou-Donia et al. [39] showed that the 
administration of SUCL for 12-week causes 
numerous adverse effects including reduction of 
fecal microbiota, increase in fecal pH and 
increase of P-gp expression, CYP3A4, CYP2D1, 
which may limit the bioavailability of orally 
administered drugs.   
 
In a recent study by Saucedo-Vence [40], in carp 
exposed to SUCL diluted in water, they found 
high concentrations of the sweetener in different 
organs; in addition to high concentrations of 
carbonylated proteins in blood, the authors 
suggest that damage to biomolecules, such as 
carbonylation of proteins, are directly related to 
the presence of SUCL. This situation is similar to 
that reported in this study, since the diluted 
SUCL was administered in the drinking water 
and its exposure was continuous. Based on the 
above, it can be observed that, although a low 
percentage is absorbed (15%) in the organism, 
this proportion could reach the tissues; 
particularly blood, a situation that is still 
controversial, since the studies are inconclusive. 
Some research suggests that there are adverse 
toxic effects, both acute and chronic at the 
biological level [39,41,42], our findings suggest 
that they do cause an effect on peripheral blood 
lymphocytes, generating the production of high 
concentrations of carbonylated proteins in the 
group of mice exposed to SUCL consumption, a 




Blood glucose concentration increased in the 
group of mice that consumed SUCL for 12-week, 
a situation that would explain the increase in 
carbonylated proteins, furthermore, prolonged 
consumption of ST did not increase glycaemia or 
carbonylated proteins. It is necessary to evaluate 
other markers of oxidative stress in the 
lymphocytes to determine its presence with the 
consumption of sweeteners for a prolonged time. 
Consumption of SUCL increases the absorption 
of glucose from the diet, therefore, the more 
SUCL is consumed, may lead to increased 
uptake of glucose, favoring chronic 
hyperglycemia states, which in the presence of 
insulin resistance favors the formation of 
advanced glycation end products. Our results 
suggest that chronic and routine consumption of 
SUCL and SUC can alter the structure of 
proteins, causing a reaction with amino acid 
residues favoring glycation and glycoxidation. 
However, it cannot be defined yet whether 
carbonylation is cause or consequence of protein 





The project from which this article derives was 
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and the guidelines of the Mexican Secretary of 
Health for the production and Care of Laboratory 
Animals (NOM-062-ZOO-1999 Ministry of 
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